Surfactant protein a binds to HIV and inhibits direct infection of cd4 + cells, but enhances dendritic cell-mediated viral transfer

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 601-609

  Gaiha, Gaurav D ^a   Dong, Tao ^b   Palaniyar, Nades ^c   Mitchell, Daniel A ^a,d   Reid, Kenneth B M ^a   Clark, Howard W ^a,e,f  

^a MRC Immunochemistry Unit   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; ENDOGLYCOSIDASE H; GLYCOPROTEIN GP 120; GLYCOSIDASE; MANNOSE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B12; MONOCLONAL ANTIBODY F105; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG; OLIGOSACCHARIDE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CHO CELL; CONTROLLED STUDY; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; NONHUMAN; PH; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION; ADOLESCENT; ADULT; ANIMAL; CELL LINE; GENETICS; HAMSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MALE; METABOLISM; PROTEIN BINDING;

ADOLESCENT; ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CRICETINAE; DENDRITIC CELLS; HIV; HIV ENVELOPE PROTEIN GP120; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MANNOSE; OLIGOSACCHARIDES; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RECOMBINANT PROTEINS;

EID: 47949084570     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.601     Document Type: Article

References (52)

1. Kuroki, Y., and D. R. Voelker. 1994. Pulmonary surfactant proteins. J. Biol. Chem. 269: 25943-25946.
2. Holmskov, U., R. Malhotra, R. B. Sim, and J. C. Jensenius. 1994. Collectins: eollagenous C-type leclins of the innate immune defense system. Immunol. Today 15: 67-74.
3. Hoppe, H. J., and K. B. Reid. 1994. Trimeric C-type lectin domains in host defence. Structure 2: 1129-1133.
4. Palaniyar, N., F. X. McCormack, F. Possmayer, and G. Harauz. 2000. Three-dimensional structure of rat surfactant protein A trimers in association with phos-pholipid monolayers. Biochemistry 39: 6310-6306.
5. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5: 58-68.
6. Tino, M. J., and J. R. Wright. 1998. Interactions of surfactant protein A with epithelial cells and phagocytes. Biochim. Biophys. Acta 1408: 241-263.
7. Wright, J. R., and D. C. Youmans. 1993. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am. J. Physiol. 264: L338-L344.
8. Gardai, S. J., Y. Q. Xiao, M. Dickinson, J. A. Nick, D. R. Voelker, K. E. Greene, and P. M. Henson. 2003. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23.
9. Wu, H., A. Kuzmenko, S. Wan, L. Schaffer, A. Weiss, J. H. Fisher, K. S. Kim, and F. X. McCormack. 2003. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J. Clin. Invest. 111: 1589-1602.
10. Crouch, E. C. 1998. Collectins and pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 19: 177-201.
11. Miyamura, K., R. Malhotra, H. J. Hoppe, K. B. Reid, P. J. Phizackerley, P. Macpherson, and A. Lopez Bernal. 1994. Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochint Biophys. Acta 1210: 303-307.
12. MacNeill, C, T. M. Umstead, D. S. Phelps, Z. Lin, J. Floras, D. A. Shearer, and J. Weisz. 2004. Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid. Immunology 111: 91-99.
13. Wei, X., J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, et al. 2003. Antibody neutralization and escape by HIV-1. Nature All: 307-312.
14. Ezekowitz, R. A., M. Kuhlman, J. E. Groopman, and R. A. Bym. 1989. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169: 185-196.
15. Meschi, J., E. C. Crouch, P. Skolnik, K. Yahya, U. Holmskov, R. Leth-Larsen, I. Tomoe, T. Tecle, M. R. White, and K. L. Hartshorn. 2005. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gpl20 and inhibits HIV replication. J. Gen. Virol. 86: 3097-3107.
16. Suwabe, A., R. J. Mason, and D. R. Voelker. 1996. Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification. Arch. Biochem. Biophys. 327: 285-291.
17. Mitchell, D. A., A. J. Fadden, and K. Drickamer. 2001. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR: sub-unit organization and binding to multivalent ligands. J. Biol. Chem. 276: 28939-28945.
18. Scanlan, C. N., R. Pantophlet, M. R. Wormald, E. O. Saphire, R. Stanfield, I. A. Wilson, H. Katinger, R. A. Dwek, P. M. Rudd, and D. R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alphal->2 mannose residues on the outer face of gpl20. J. Virol. 76: 7306-7321.
19. Hu, Q., I. Frank, V. Williams, J. J. Santos, P. Watts, G. E. Griffins, J. P. Moore, M. Pope, and R. J. Shattock. 2004. Blockade of attachment and fusion inhibits HIV-I infection of human cervical tissue. J. Exp. Med. 199: 1065-1075.
20. Rossio, J. L., M. T. Esser, K. Suryanarayana, D. K. Schneider, J. W. Bess, Jr., G. M. Vasquez, T. A. Wiltrout, E. Chertova, M. K. Grimes, Q. Sattentau, et al. 1998. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of cpnformational and functional integrity of virion surface proteins. J. Virol. 72: 7992-8001.
21. Valore, E. V., C. H. Park, S. L. Igreti, and T. Ganz. 2002. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol. 187: 561-568.
22. Pastore, C., A. Ramos, and D. E. Mosier. 2004. Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching. J. Virol. 78: 7565-7574.
23. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gpl20) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265: 10373-10382.
24. Zhu, X., C. Borchers, R. J. Bienstock, and K. B. Tomer. 2000. Mass spectro-metric characterization of the glycosylation pattern of HIV-gpl20 expressed in CHO cells. Biochemistry 39: 11194-11204.
25. Maley, F., R. B. Trimble, A. L. Tarentino, and T. H. Plummer, Jr. 1989. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180: 195-204.
26. Fauci, A. S., G. Pantaleo, S. Stanley, and D. Weissman. 1996. Immunopathogenic mechanisms of HIV infection. Ann. Intern. Med. 124: 654-663.
27. Esser, M. T., T. Mori, I. Mondor, Q. J. Sattentau, B. Dey, E. A. Berger, M. R. Boyd, and J. D. Lifson. 1999. Cyanovirin-N binds to gpl20 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gpl20 or soluble CD4-induced conformational changes in gpl20. J. Virol. 73: 4360-4371.
28. Gaynor, C. D., F. X. McCormack, D. R. Voelker, S. E. McGowan, and L. S. Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155: 5343-5351.
29. Pasula, R., J. F. Downing, J. R. Wright, D. L. Kachel, T. E. Davis, Jr., and W. J. Martin, Jr. 1997. Surfactant protein A (SweP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17: 209-217.
30. Hickman-Davis, J., J. Gibbs-Erwin, J. R. Lindsey, and S. Matalon. 1999. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc. Natl. Acad. Sci. USA 96: 4953-4958.
31. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
32. Granelli-Piperno, A., A. Pritsker, M. Pack, I. Shimeliovich, J. F. Arrighi, C. G. Park, C. Trumpfheller, V. Piguet, T. M. Moran, and R. M. Steinman. 2005. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175: 4265-4273.
33. Rappocciolo, G., P. Piazza, C. L. Fuller, T. A. Reinhart, S. C. Watkins, D. T. Rowe, M. Jais, P. Gupta, and C. R. Rinaldo. 2006. DC-SIGN on B lymphocytes is required for transmission of HIV-I to T lymphocytes. PLoS Pathog. 2: e70.
34. Poulain, F. R., L. Allen, M. C. Williams, R. L. Hamilton, and S. Hawgood. 1992. Effects of surfactant apolipoproteins on liposome structure: implications for tubular myelin formation. Am. J. Physiol. 262: L730-L739.
35. Hong, P. W., K. B. Flummerfelt, A. de Parseval, K. Gumey, J. H. Elder, and B. Lee. 2002. Human immunodeficiency virus envelope (gpl20) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gpl20-DC-SIGN binding. J. Virol. 76: 12855-12865.
36. Hart, M. L., M. Saifuddin, and G. T. Spear. 2003. Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. J. Gen. Virol. 84: 353-360.
37. Malhotra, R., J. S. Haurum, S. Thiel, and R. B. Sim. 1994. Binding of human collectins (SP-A and MBP) to influenza virus. Biochem. J. 304: 455-461.
38. Hartshorn, K. L., M. R. White, V. Shepherd, K. Reid, J. C. Jensenius, and E. C. Crouch. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 273: LI 156-LI 166.
39. Ghildyal, R., C. Hartley, A. Varrasso, J. Meanger, D. R. Voelker, E. M. Anders, and J. Mills. 1999. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J. Infect. Dis. 180: 2009-2013.
40. van de Graaf, E. A., H. M. Janscn, R. Lutter, C. Alberts, J. Kobesen, I. J. de Vries, and T. A. Out. 1992. Surfactant protein A in bronchoalveolar lavage fluid. J. Lab. Clin. Med. 120: 252-263.
41. Downing, J. F., R. Pasula, J. R. Wright, H. L. Twigg, III, and W. J. Martin, Jr. 1995. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 92: 4848-4852.
42. Snyder, J. M., J. E. Kwun, J. A. O'Brien, C. R. Rosenfeld, and M. J. Odom. 1988. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr. Res. 24: 728-734.
43. Condon, J. C, P. Jeyasuriya, J. M. Faust, and C. R. Mendelsohn. 2004. Surfactant Protein A secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc. Natl. Acad. Sci. USA 101: 4978-4983.
44. Venkataraman, N., A. L. Cole, P. Svoboda, J. Pohl, and A. M. Cole. 2005. Cationic polypeptides are required for anti-HIV-l activity in human vaginal fluid. J. Immunol. 175: 7560-7567.
45. Guay, L. A., J. G. Sierra-Madero, C. K. Finegan, and E. A. Rich. 1997. Mediation of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A. Am. J. Respir. Cell Mol. Biol. 16: 421-428.
46. Turville, S. G., J. Arthos, K. M. Donald, G. Lynch, H. Naif, G. Clark, D. Hart, and A. L. Cunningham. 2001. HIV gpl20 receptors on human dendritic cells. Blood 98: 2482-2488.
47. Martin, L. S., J. S. McDougal, and S. L. Loskoski. 1985. Disinfection and inactivation of the human T Iymphotropic virus type III/Lymphadenopathy- associated virus. J. Infect. Dis. 152: 400-403.
48. Ongradi, J., L. Ceccherini-Nelli, M. Pistello, S. Specter, and M. Bendinelli. 1990. Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications. AIDS Res. Hum. Retroviruses 6: 1433-1436.
49. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185: 621-628.
50. Guo, Y., H. Feinberg, E. Conroy, D. A. Mitchell, R. Alvarez, O. Blixt, M. E. Taylor, W. I. Weis, and K. Drickamer. 2004. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11: 591-598.
51. Nepomuceno, R. R., A. H. Henschen-Edman, W. H. Burgess, and A. J. Tenner. 1997. cDNA cloning and primary structure analysis of ClqR(P), the human Clq/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6: 119-129.
52. Chroneos, Z. C, R. Abdolrasulnia, J. A. Whitsett, W. R. Rice, and V. L. Shepherd. 1996. Purification of a cell-surface receptor for surfactant protein A. J. Biol. Chem. 271: 16375-16383.